Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.01389
Abstract: The oncogene MDMX, also known as MDM4 is a critical negative regulator of the tumor suppressor p53 and has been implicated in the initiation and progression of human cancers. Increasing evidence indicates that MDMX is… read more here.
Keywords: targeting mdmx; mdmx; cancer; p53 ... See more keywords